2018 American Transplant Congress
Liposomal Bupivacaine: Friend or Foe in Kidney Donation?
Henry Ford Hospital, Detroit, MI.
Background: Pain following nephrectomy and concerns for opioid dependence are disincentives to living kidney donors (LKD). Efficacy of liposomal bupivacaine (LB) in post-operative care of…2018 American Transplant Congress
An Initial Experience with the Endowrist Robotic Endostapling Device for Renal Donor Nephrectomy
Piedmont Transplant Institute, Atlanta.
Introduction:Robot assisted donor nephrectomy has been used an advancement to standard laparoscopic techniques. However, limitations in available instrumentation reduce the efficiency of the procedure especially…2018 American Transplant Congress
Kidney Transplantation Alone in End-Stage Renal Disease Patients with Hepatitis B Liver Cirrhosis
BackgroundKidney transplantation (KT) alone in end-stage renal disease (ESRD) patients with hepatitis B virus-induced liver cirrhosis (LC) remains controversial. This study compared outcomes of KT…2018 American Transplant Congress
Conversion to Mizoribine with Mycophenolate Eliminates or Reduces the BK Virus Load in Kidney Transplant Recipients: A Prospective Study
Organ Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Background: BK virus (BKV) allograft nephropathy (BKVAN) is a graft-threatening complication after kidney transplantation. Current consensus regarding the prevention of BKVAN is to screen for…2018 American Transplant Congress
Targeting Plasma Cells with Anti-CD38mAb (Daratumumab) and CXCR4 Antagonist (Plerixafor) for Desensitization
1Surgery, Duke University, Durham, NC; 2Surgery, Mayo Clinic, Rochester, MN.
[Introduction] Sensitized patients comprise a significant portion (30%) of candidates on the transplant waiting list. Unfortunately for sensitized patients, the presence of donor-specific antibodies (DSA)…2018 American Transplant Congress
Evaluation of a Marine OXYgen Carrier (Hemo2Life®) for Organ Preservation: First Use in Kidney Transplantation in Humans
Preventing ischemia/reperfusion injuries (IRIs) is a major issue in organ transplantation. At present, grafts are preserved at 4[deg]C in preservation solution in order to reduce…2018 American Transplant Congress
Does DGF Result in Worse Outcomes in a Second Transplant?
Delayed graft function (DGF) is a risk factor for patient death, kidney allograft loss, reduced allograft function and acute rejection after kidney transplantation. Prior transplant…2018 American Transplant Congress
Pilot Study of Health IT Feasibility and Impact on Quality of Life for Young Adult Kidney Transplant Recipients
Nephrology, University of Washington, Seattle, WA.
Background: Young adult kidney transplant recipients (KTRs) are an at-risk population and long-term survival rates are significantly lower than expected. A large majority of young…2018 American Transplant Congress
Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation
Delayed graft function (DGF) is considered as a risk factor for long-term allograft failure and rejection episodes.There is currently no biomarker in the immediate post-kidney…2018 American Transplant Congress
Treatment of HCV Infection in Renal Transplant Recipients
Renal Transplant Unit, Instituto de Nefrologia Nephrology, Buenos Aires, Argentina.
HCV infection is associated to chronic hepatitis, cirrhosis, hepatic carcinoma and increased incidence of diabetes. Combination of new antiviral drugs have demonstrated utility in liver…
- « Previous Page
- 1
- …
- 309
- 310
- 311
- 312
- 313
- …
- 531
- Next Page »